Search Results - "Tewes, Frederic"

Refine Results
  1. 1

    Control of the Lung Residence Time of Highly Permeable Molecules after Nebulization: Example of the Fluoroquinolones by Brillault, Julien, Tewes, Frédéric

    Published in Pharmaceutics (23-04-2020)
    “…Pulmonary drug delivery is a promising strategy to treat lung infectious disease as it allows for a high local drug concentration and low systemic side…”
    Get full text
    Journal Article
  2. 2

    (E, E)-farnesol and myristic acid-loaded lipid nanoparticles overcome colistin resistance in Acinetobacter baumannii by Faivre, Carla, Imtiyaz, Farras Daffa, Buyck, Julien M., Marchand, Sandrine, Marcotte, Melissa, Henry, Thomas, Anton, Nicolas, Collot, Mayeul, Tewes, Frédéric

    Published in International journal of pharmaceutics (25-12-2024)
    “…[Display omitted] The rise of colistin-resistant Acinetobacter baumannii has severely limited treatment options for infections caused by this pathogen. While…”
    Get full text
    Journal Article
  3. 3

    Sustained-release microparticle dry powders of chloramphenicol palmitate or thiamphenicol palmitate prodrugs for lung delivery as aerosols by Nurbaeti, Siti Nani, Brillault, Julien, Tewes, Frédéric, Olivier, Jean-Christophe

    “…The purpose of this study was to design inhalable sustained-release nanoparticle-in-microparticles, i.e. nano-embedded microparticles, for the lung delivery of…”
    Get full text
    Journal Article
  4. 4

    Amorphous Calcium Carbonate Based-Microparticles for Peptide Pulmonary Delivery by Tewes, Frederic, Gobbo, Oliviero L, Ehrhardt, Carsten, Healy, Anne Marie

    Published in ACS applied materials & interfaces (20-01-2016)
    “…Amorphous calcium carbonate (ACC) is known to interact with proteins, for example, in biogenic ACC, to form stable amorphous phases. The control of…”
    Get full text
    Journal Article
  5. 5

    In vitro evaluation of Pseudomonas aeruginosa chronic lung infection models: Are agar and calcium-alginate beads interchangeable? by Torres, Bruna Gaelzer Silva, Awad, Rana, Marchand, Sandrine, Couet, William, Tewes, Frederic

    “…[Display omitted] Animal models of chronic lung infection with P. aeruginosa (PA) are useful tools to improve antibiotic (ATB) treatment. Two main models based…”
    Get full text
    Journal Article
  6. 6

    Assessment of inhaled cationic antibiotics in an in vitro model of Pseudomonas aeruginosa lung biofilm by Awad, Rana, Marchand, Sandrine, Couet, William, Nasser, Mohamad, Buyck, Julien M., Tewes, Frédéric

    Published in Microbial pathogenesis (01-12-2024)
    “…This study aimed to evaluate the efficacy of inhaled cationic antibiotics, including tobramycin (TOB) and colistin (CST), using an in vitro alginate bead model…”
    Get full text
    Journal Article
  7. 7

    Impact of mixed Staphylococcus aureus-Pseudomonas aeruginosa biofilm on susceptibility to antimicrobial treatments in a 3D in vitro model by Landa, Guillermo, Clarhaut, Jonathan, Buyck, Julien, Mendoza, Gracia, Arruebo, Manuel, Tewes, Frederic

    Published in Scientific reports (13-11-2024)
    “…Staphylococcus aureus and Pseudomonas aeruginosa are the most common bacteria co-isolated from chronic infected wounds. Their interactions remain unclear but…”
    Get full text
    Journal Article
  8. 8

    Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections by Brunet, Kévin, Martellosio, Jean-Philippe, Tewes, Frédéric, Marchand, Sandrine, Rammaert, Blandine

    Published in Pharmaceutics (14-03-2022)
    “…Pulmonary mold infections are life-threatening diseases with high morbi-mortalities. Treatment is based on systemic antifungal agents belonging to the families…”
    Get full text
    Journal Article
  9. 9

    New aerosol formulation to control ciprofloxacin pulmonary concentration by Lamy, Barbara, Tewes, Frederic, Serrano, Dolores Remedios, Lamarche, Isabelle, Gobin, Patrice, Couet, William, Healy, Anne Marie, Marchand, Sandrine

    Published in Journal of controlled release (10-02-2018)
    “…Ciprofloxacin (CIP) apparent permeability across a pulmonary epithelium model can be controlled by the affinity of its complex with a metal cation. The higher…”
    Get full text
    Journal Article
  10. 10

    Moisture diffusion and permeability characteristics of hydroxypropylmethylcellulose and hard gelatin capsules by Barham, Ahmad S., Tewes, Frederic, Healy, Anne Marie

    Published in International journal of pharmaceutics (30-01-2015)
    “…[Display omitted] The primary objective of this paper is to compare the sorption characteristics of hydroxypropylmethylcellulose (HPMC) and hard gelatin (HG)…”
    Get full text
    Journal Article
  11. 11

    Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous/nanoparticulate microparticles (NPMPs) for inhalation by Amaro, Maria Inês, Tewes, Frederic, Gobbo, Oliviero, Tajber, Lidia, Corrigan, Owen I., Ehrhardt, Carsten, Healy, Anne Marie

    Published in International journal of pharmaceutics (10-04-2015)
    “…[Display omitted] A challenge exists to produce dry powder inhaler (DPI) formulations with appropriate formulation stability, biological activity and suitable…”
    Get full text
    Journal Article
  12. 12

    Lipid Nanoparticles Loaded with Farnesol or Geraniol to Enhance the Susceptibility of E. coli MCR-1 to Colistin by Valcourt, Chantal, Buyck, Julien M., Grégoire, Nicolas, Couet, William, Marchand, Sandrine, Tewes, Frédéric

    Published in Pharmaceutics (01-11-2021)
    “…Resistance to colistin, one of the antibiotics of last resort against multidrug-resistant Gram-negative bacteria, is increasingly reported. Notably, MCR…”
    Get full text
    Journal Article
  13. 13

    In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa by Tewes, Frédéric, Bahamondez-Canas, Tania F., Moraga-Espinoza, Daniel, Smyth, Hugh D.C., Watts, Alan B.

    “…[Display omitted] A significant limitation of locally delivered treatments for chronic pulmonary infections is often the short residence time within the…”
    Get full text
    Journal Article
  14. 14

    PK-PD Evaluation of Inhaled Microparticles loaded with Ciprofloxacin-Copper complex in a Rat Model of Chronic Pseudomonas aeruginosa Lung Infection by Tewes, Frederic, Lamy, Barbara, Laroche, Julian, Lamarche, Isabelle, Marchand, Sandrine

    Published in International journal of pharmaceutics: X (01-12-2023)
    “…The potential gain in efficacy of pulmonary administration over IV administration of some antibiotics such as ciprofloxacin (CIP) may be limited by the short…”
    Get full text
    Journal Article
  15. 15

    Optimization of levofloxacin-loaded crosslinked chitosan microspheres for inhaled aerosol therapy by Gaspar, Marisa C., Sousa, João J.S., Pais, Alberto A.C.C., Cardoso, Olga, Murtinho, Dina, Serra, M. Elisa S., Tewes, Frédéric, Olivier, Jean-Christophe

    “…[Display omitted] The aim of this work was the development of innovative levofloxacin-loaded swellable microspheres (MS) for the dry aerosol therapy of…”
    Get full text
    Journal Article
  16. 16

    Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11 by Moreau, Jérémy, Noël, Thierry, Point, Kévin, Tewes, Frédéric, Deroche, Luc, Clarhaut, Jonathan, Fitton‐Ouhabi, Valérie, Perraud, Estelle, Marchand, Sandrine, Buyck, Julien M., Brunet, Kévin

    Published in Mycoses (01-03-2024)
    “…Background Meyerozyma guilliermondii is a yeast species responsible for invasive fungal infections. It has high minimum inhibitory concentrations (MICs) to…”
    Get full text
    Journal Article
  17. 17

    Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms by Tewes, Frederic, Bahamondez-Canas, Tania F., Smyth, Hugh D. C.

    Published in AAPS PharmSciTech (01-07-2019)
    “…A limitation of antibiotic treatments for P. aeruginosa (PA) chronic pulmonary infections is the reduced efficacy due to sub-therapeutic concentrations at the…”
    Get full text
    Journal Article
  18. 18

    Formulation of rifampicin–cyclodextrin complexes for lung nebulization by Tewes, Frédéric, Brillault, Julien, Couet, William, Olivier, Jean-Christophe

    Published in Journal of controlled release (14-07-2008)
    “…Lung administration of antibiotics by nebulization is promising for improving treatment efficiency for pulmonary infections, as it increases drug concentration…”
    Get full text
    Journal Article
  19. 19

    Comparison between Colistin Sulfate Dry Powder and Solution for Pulmonary Delivery by Tewes, Frédéric, Brillault, Julien, Gregoire, Nicolas, Olivier, Jean-Christophe, Lamarche, Isabelle, Adier, Christophe, Healy, Anne-Marie, Marchand, Sandrine

    Published in Pharmaceutics (17-06-2020)
    “…To assess the difference in the fate of the antibiotic colistin (COLI) after its pulmonary delivery as a powder or a solution, we developed a COLI powder and…”
    Get full text
    Journal Article
  20. 20

    Improved In Vitro Anti- Mucorales Activity and Cytotoxicity of Amphotericin B with a Pegylated Surfactant by Brunet, Kévin, Diop, Cheikh A B, Chauzy, Alexia, Prébonnaud, Noémie, Marchand, Sandrine, Rammaert, Blandine, Tewes, Frédéric

    Published in Journal of fungi (Basel) (27-01-2022)
    “…The aim of this study was to evaluate the effect of the combination of amphotericin B (AmB) and various non-ionic surfactants on the anti- activity of AmB, the…”
    Get full text
    Journal Article